Latest current cash for GRNAW: $32M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
GreenLight Biosciences- Warrants (30/09/2027) (GRNAW) currently reports a current cash of $32M as of March 2023. That compares with $83M in the prior-year period — down 61.1% year over year. Use the charts on this page to explore GreenLight Biosciences- Warrants (30/09/2027)'s current cash history and peer comparisons.
GreenLight Biosciences- Warrants (30/09/2027)'s current cash decreased from $83M to $32M — a 61.1% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
GreenLight Biosciences- Warrants (30/09/2027) reported $32M in current cash as of March 2023. That compares with $83M in the prior-year period — down 61.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $32M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GreenLight Biosciences- Warrants (30/09/2027), and consider following GRNAW for alerts when major investors trade the stock.